AngioDynamics shares are trading lower after the company reported worse-than-expected Q1 revenue results.
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics shares fell after the company reported Q1 revenue results that were worse than expected.
October 03, 2024 | 2:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AngioDynamics reported Q1 revenue results that were below expectations, leading to a decline in its share price.
The company's worse-than-expected Q1 revenue results directly impacted its stock price negatively, as investors reacted to the disappointing financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100